Gregory J. Dore

Active 1995–2025

Also published as
Gregory J Dore
230
Papers
33,749
Citations
100
h-index
220
i10-index

Citations

Citations per year for Gregory J. Dore1986: 2 citations1988: 1 citations1996: 1 citations1997: 1 citations1998: 3 citations1999: 2 citations2000: 11 citations2001: 15 citations2002: 21 citations2003: 39 citations2004: 51 citations2005: 65 citations2006: 55 citations2007: 79 citations2008: 67 citations2009: 99 citations2010: 160 citations2011: 172 citations2012: 147 citations2013: 199 citations2014: 219 citations2015: 269 citations2016: 272 citations2017: 316 citations2018: 403 citations2019: 1,422 citations2020: 1,029 citations2021: 868 citations2022: 732 citations2023: 649 citations2024: 1,120 citations2025: 342 citations2026: 11 citations1987: no citations, so this year is not shown1989–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,111 citing papers, 21.2% of this breakdownUnited Kingdom: 791 citing papers, 7.9% of this breakdownAustralia: 739 citing papers, 7.4% of this breakdownChina: 544 citing papers, 5.4% of this breakdownGermany: 463 citing papers, 4.6% of this breakdownCanada: 447 citing papers, 4.5% of this breakdownItaly: 438 citing papers, 4.4% of this breakdownFrance: 416 citing papers, 4.2% of this breakdownSpain: 326 citing papers, 3.3% of this breakdownSwitzerland: 256 citing papers, 2.6% of this breakdownJapan: 204 citing papers, 2% of this breakdownNetherlands: 187 citing papers, 1.9% of this breakdown
0%21.2%Other 30.6%

Fields

  • Medicine82.3%
  • Immunology and Microbiology6.9%
  • Biochemistry, Genetics and Molecular Biology6.1%
  • Neuroscience0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Social Sciences0.5%
  • Other3.2%

Topics

  • Hepatitis C virus research17.8%
  • Hepatitis B Virus Studies9.9%
  • Liver Disease Diagnosis and Treatment8.5%
  • HIV, Drug Use, Sexual Risk4%
  • HIV/AIDS drug development and treatment2.9%
  • Long-Term Effects of COVID-192.6%
  • Other54.3%

Coauthors

All papers

Open in search
  1. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

    Authors: , , , , , , , , , , , - Nature Immunology 2022 cited by 1,003

  2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ziv Ben‐Ari, Fernando Bessone, Mia J. Biondi, Abdul Rahman Bizri, Carlos Eduardo Brandão‐Mello, Krestina Brigida, Kimberly Brown, Robert S. Brown, Philip Bruggmann, Maurizia Rossana Brunetto, Dana Busschots, Marı́a Buti, Maia Butsashvili, Joaquín Cabezas, Chungman Chae, Viktorija Chaloska Ivanova, Henry Lik‐Yuen Chan, Hugo Cheinquer, Kent Jason G. Cheng, Myeong-Eun Cheon, Cheng‐Hung Chien, Rong‐Nan Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, B. Coco, Fernando A Contreras, Markus Cornberg, Matthew Cramp, Javier Crespo, Fuqiang Cui, Chris Cunningham, Lucy Dagher Abou, Olav Dalgård, Doan Y Dao, Victor de Lédinghen, Moutaz Derbala, Keshab Deuba, Karan Dhindsa, Samsuridjal Djauzi, Sylvia Dražilová, Ann‐Sofi Duberg, Mohammed Elbadri, Manal H. El‐Sayed, Gamal Esmat, Chris Estes, Sameera Ezzat, Martti Färkkilâ, Laurent Ferradini, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Tajana Filipec Kanižaj, Robert Flisiak, Soňa Fraňková, James Fung, Amiran Gamkrelidze, Edward Gane, Virginia Garcia, Javier García‐Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe, Pierre M. Gholam, Adrian Goldis, Magnús Gottfreðsson, Richard T. Gray, Jason Grebely, Michael Gschwantler and 158 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 653

  3. AP-1 imprints a reversible transcriptional programme of senescent cells

    Authors: , , , , , , , , , , , - Nature Cell Biology 2020 cited by 252

  4. Necroptosis microenvironment directs lineage commitment in liver cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2018 cited by 424

  5. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2023 cited by 263

  6. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Z. Wiktor, Ayman A. Abdo, Rakesh Aggarwal, Alessio Aghemo, Bandar Al‐Judaibi, Mamun Al Mahtab, Arshad Altaf, Zyaad Ameen, Tarik Asselah, Oidov Baatarkkhuu, Ella Barber, Eleanor Barnes, Pascale Boulet, Louise Burrows, Maia Butsashvili, Erica On-Ting Chan, Chelsea Chow, Ben Cowie, Chris Cunningham, Alexandre de Araújo, Graciela Diap, Gregory J. Dore, Joseph Doyle, Manal H. El‐Sayed, Emmanuel Fajardo, Ed Gane, Aneley Getahun, David Goldberg, Tiffany Got, Matthew Hickman, Andrew Hill, Sharon Hutchinson, Christopher R. Jones, Saleem Kamili, Amreen Khan, Alice Lee, Tin Yan Lee, Jioiji Malani, Tammy Meyers-Morris, Shevanthi Nayagam, Richard Njouom, Ponsiano Ocama, Alisa Pedrana, Rosanna Ŵ. Peeling, Amulya Reddy, Jilian A. Sacks, Shiv Kumar Sarin, Yusuke Shimakawa, Marcela Silva, Pavlo Skala, Simon D. Taylor‐Robinson, Alexander Thompson, Mark Thursz, Alfred Tonganibeia, Jack Wallace, James Ward, Fernando Herz Wolff, Peter Vickerman, Johnny Yau - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 540

  7. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abdullah M. Assiri, Oidov Baatarkhuu, Abate Bane, Ziv Ben‐Ari, Colm Bergin, Fernando Bessone, Florian Bihl, Abdul Rahman Bizri, Martin Blachier, Antonio Javier Blasco, Carlos Eduardo Brandão‐Mello, Philip Bruggmann, Cheryl Brunton, Filipe Calinas, Henry Lik‐Yuen Chan, Asad Chaudhry, Hugo Cheinquer, Chien‐Jen Chen, Rong‐Nan Chien, Moon Seok Choi, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, Mette Rye Clausen, Matthew Cramp, Antonio Craxı̀, Esther A. Croes, Olav Dalgård, Jorge Daruich, Victor de Lédinghen, Gregory J. Dore, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Chris Estes, Karolin Falconer, Elmoubasher Farag, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Robert Flisiak, Soňa Fraňková, Ivane Gamkrelidze, Ed Gane, Javier García‐Samaniego, Amir Ghafoor Khan, Ilias Gountas, Adrian Goldis, Magnús Gottfreðsson, Jason Grebely, Michael Gschwantler, Mário Guimarães Pessôa, J. Gunter, Behzad Hajarizadeh, O. Hajelssedig, Saeed Hamid, Waseem Hamoudi, Angelos Hatzakis, Sayed Himatt, Harald Hofer, Irena Hrstić, Yee-Tak Hui, Béla Hunyady, Ramazan Idılman, Wasim Jafri, Rohani Jahis, Naveed Z. Janjua, Peter Jarčuška, Agita Jēruma, Jón G. Jónasson and 122 more - ˜The œLancet. Gastroenterology & hepatology 2016 cited by 2,032

  8. Hepatitis C

    Authors: , , , - The Lancet 2023 cited by 164

  9. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 132

  10. HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis

    Authors: , , , , - Hepatology 2022 cited by 106

  11. openalex_id:w4220994910

    Authors: , , , , , , , , , , , , , , , , cited by 104

  12. A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Metabolism 2024 cited by 61

  13. A multinational Delphi consensus to end the COVID-19 public health threat

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabina Faiz Rashid, Magdalena Rathe, Rocío Sáenz, Sudhvir Singh, Malene Trock-Hempler, Sonia Villapol, Peiling Yap, Agnès Binagwaho, Adeeba Kamarulzaman, Ayman El-Mohandes, The COVID-19 Consensus Statement Panel, Maurício L. Barreto, Carlos del Rı́o, Salim Abdulla, Sarah Addleman, Gulnara Aghayeva, Raymond Agius, Mohammed Ahmed, Mohamed Ramy, Pedro Aíde, Soo Aleman, Jean-Patrick Alfred, Shamim Ali, J. Aliaga, Tammam Aloudat, Saleh A. Alqahtani, Jameela Alsalman, John Amuasi, Anurag Agrawal, Wagida A. Anwar, Tânia Cremonini de Araújo-Jorge, Osvaldo Artaza, Leyla Asadi, Yaw Asante Awuku, Michael G. Baker, Lorena Barberia, Ernesto Báscolo, Paul Belcher, Lizett Bell, Adele Schwartz Benzaken, Emil J. Bergholtz, Nahid Bhadelia, Anant Bhan, Stéphane Bilodeau, Ricardo Bitrán, Philomena M. Bluyssen, A Bosman, Fernando A. Bozza, Melanie M. Brinkmann, Andrew Brown, B. Mellado, Elizabeth A. Bukusi, Chris Bullen, Giorgio Buonanno, Rochelle A. Burgess, Matthew Butler, Pauline Byakika‐Kibwika, Báltica Cabieses, Gunilla Carlsson, Fidelia Cascini, Chishala Chabala, M. Chakroun, Kar Keung Cheng, Agnes Chetty, Dmytro Chumachenko, Gregg Consalves, Andrew Conway Morris, Ahmed Cordie, Tumani Corrah, Brenda Crabtree‐Ramírez and 252 more - Nature 2022 cited by 238

  14. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

    Authors: , , , , , , , , , , , , , - The Lancet Global Health 2023 cited by 131

  15. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

    Authors: , , , , , , , - Journal of Hepatology 2017 cited by 500

  16. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

    Authors: , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 181

  17. A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study

    Authors: , , , , , , , , , , - Journal of Hepatology 2023 cited by 53

  18. Epidemiology and natural history of HCV infection

    Authors: , , - Nature Reviews Gastroenterology & Hepatology 2013 cited by 997

  19. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

    Authors: , , , , , , , , , , , - medRxiv 2021 cited by 89

  20. Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars

    Authors: , , , , , , , , , , - Cell Genomics 2023 cited by 44

  21. Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs

    Authors: , , , , , , , , , , , , , , , , , - Addiction 2018 cited by 259

  22. The kynurenine pathway relates to post‐acuteCOVID‐19 objective cognitive impairment andPASC

    Authors: , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2023 cited by 46

  23. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

    Authors: , , - Journal of Viral Hepatitis 2005 cited by 871

  24. Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jens Kort, Bo Fu, Ran Liu, Teresa I. Ng, Tami Pilot-Matias, Chih‐Wei Lin, Roger Trinh, Federico Mensa - New England Journal of Medicine 2018 cited by 437